Akebia Therapeutics
AKBA
AKBA
103 hedge funds and large institutions have $57.4M invested in Akebia Therapeutics in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 114 → 103 (-11)
28% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 32
45% less capital invested
Capital invested by funds: $104M → $57.4M (-$46.9M)
Holders
103
Holding in Top 10
1
Calls
$1.11M
Puts
$510K
Top Buyers
| 1 | +$9.28M | |
| 2 | +$2.77M | |
| 3 | +$2.14M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.07M |
| 5 |
Bank of New York Mellon
New York
|
+$598K |
Top Sellers
| 1 | -$7.61M | |
| 2 | -$3.28M | |
| 3 | -$1.54M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.27M |
| 5 |
Goldman Sachs
New York
|
-$1.09M |